Abiomed Inc.
US ˙ NASDAQ ˙ US0036541003
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityABMD / Abiomed Inc.
InstitutionSuntrust Banks Inc
Latest Disclosed Ownership1,397 shares
Latest Disclosed Value $ 249,000
Suntrust Banks Inc reports 66.51% decrease in ownership of ABMD / Abiomed Inc.

On November 12, 2019 - Suntrust Banks Inc filed a 13F-HR form disclosing ownership of 1,397 shares of Abiomed Inc. (US:ABMD) valued at $248,512 USD as of September 30, 2019. The entity filed a previous 13F-HR on August 6, 2019 disclosing 4,172 shares of Abiomed Inc.. This represents a change in shares of -66.51% during the quarter. The current value of the position is $532,285 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2019-11-12 2019-09-30 13F ABIOMED COM 003654100 1,397 -2,775 -66.51 249 -77.09 0.0013
2019-08-06 2019-06-30 13F ABIOMED COM 003654100 4,172 -294 -6.58 1,087 -14.81 0.0057
2019-05-15 2019-03-31 13F ABIOMED COM 003654100 4,466 -452 -9.19 1,276 -20.15 0.0067
2019-02-14 2018-12-31 13F ABIOMED COM 003654100 4,918 -5,100 -50.91 1,598 -64.53 0.0092
2019-09-04 2018-09-30 13F/A-1 ABIOMED COM 003654100 10,018 5,490 121.25 4,505 143.25 0.0233
2018-11-14 2018-09-30 13F ABIOMED COM 003654100 10,021 5,493 4,506
2019-09-04 2018-06-30 13F/A-1 ABIOMED COM 003654100 4,528 503 12.50 1,852 58.16 0.0101
2018-08-14 2018-06-30 13F ABIOMED COM 003654100 4,562 514 1,865
2019-09-04 2018-03-31 13F/A-2 ABIOMED COM 003654100 4,025 -43,138 -91.47 1,171 -4.56 0.0065
2018-05-25 2018-03-31 13F/A-1 ABIOMED COM 003654100 4,048 23 1,177 0.0062
2018-05-14 2018-03-31 13F ABIOMED COM 003654100 3,949 1,149
2014-05-14 2014-03-31 13F ABIOMED COM 003654100 47,163 -43,716 -48.10 1,227 -49.49 0.0045
2014-02-12 2013-12-31 13F ABIOMED COM 003654100 90,879 -563 -0.62 2,429 39.44 0.0095
2013-11-04 2013-09-30 13F/A-1 ABIOMED COM 003654100 91,442 -1,205 -1.30 1,742 -12.77 0.0068
2013-10-31 2013-09-30 13F ABIOMED COM 003654100 91,442 1,742
2013-09-06 2013-06-30 13F/A-1 ABIOMED INC COM COM 003654100 92,647 92,647 1,997 0.0088
2013-08-15 2013-06-30 13F ABIOMED INC COM COM 003654100 92,647 1,997
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.